STAFF PROFILE
Professor Tony Zhang
Position:
Associate Dean, Academic Operations
College / Portfolio:
STEM College
School / Department:
STEM|Health and Biomedical Sciences
Phone:
+61399257758
Email:
tony.zhang@rmit.edu.au
Campus:
Bundoora West
Contact me about:
Research supervision
Professor Tony Zhang is the Associate Dean (Academic Operations) in the School of Health and Biomedical Sciences. His areas of teaching and research are public health, evidence based clinical research, clinical epidemiology, systematic review and research methodologies.
- Associate Dean (Academic Operations), School of Health and Biomedical Sciences
- Co-Deputy Director, China-Australia International Research Centre for Chinese Medicine
Postgraduate supervision
- Completion: 24 PhD, one MPhil and one BHSci (Hons),
- Current: 6 PhD
Research funding sources
- Industry funding: approx.: > 1 million.
- PhD research scholarship in the area of Traditional Chinese Medicine at RMIT. A$132,000. 2019-2024. Contract research.
- NHMRC Project Grant (No. 616609). A$560,375. 2010-2015. The effect of a standardised ginseng extract in patients with moderate COPD: a randomised, double-blind trial.
- National Institute of Complementary Medicine Research Grant. A$33,000. 2009-2010. Efficacy and safety of a standardised ginseng extract for patients with moderate COPD.
- Department of Human Services, State Government of Victoria. A$48,000. 2008-2009. Acupuncture for acute pain management at a hospital emergency department.
- Department of Innovation, Industry and Regional Services, State Government of Victoria. A$208,000. 2006–2008. Herbal medicine used by Victorians.
Competitive teaching grants
- New Colombo Plan (for Clinical placement), Department of Foreign Affairs and Trade, Australian Government, A$660,000. 2018-2022.
- New Colombo Plan (for Clinical placement), Department of Foreign Affairs and Trade, Australian Government, A$154,000. 2017.
- Short Term Mobility Program (for Clinical placement), Department of Education, Australian Government, A$11,500. 2014.
- Inaugural AsiaBound Grant, Department of Industry, Innovation, Climate Change, Science, Research and Tertiary Education, Australian Government, A$21,500. 2013.
Awards
- Adjunct Professor, Guangxi International Zhuang Medicine Hospital, China, 2023-2025
- Adjunct Professor, Shanghai University of Medicine and Health Sciences, China, 2023-2026
- Visiting Professor, The Education University of Hong Kong, China, 2019-2021
- Visiting Fellow, Faculty of Health, University of Technology Sydney, Australia, 2014-2021
- Commendation for the STEM Research Team Award (Team Award), STEM College, RMIT, 2023
- Citations for Outstanding Contributions to Student Learning (Program Award) “For holistic, innovative, problem-based teaching that enables students to blend Western medical science with traditional knowledge so as to become competent, evidence-based Chinese medicine practitioners”. Office for Learning & Teaching, Department of Industry, Innovation, Science, Research and Tertiary Education, Australian Government, Sept 2013.
- RMIT Teaching Award in Innovation in Curricula, Learning and Teaching (Program Award), Nov 2012.
- Research Excellence Award, National Institute of Complementary Medicine, Australia, Jun 2009
Research interests
- Evidence-based public health research; Epidemiological studies; Randomised controlled trial; Systematic review and meta-analysis; Clinical epidemiology; Biostatistics and Research methods.
By email.
- PhD, RMIT University, Melbourne, Australia
- Master of Public Health (MPH), University of New South Wales, Sydney, Australia
- Bachelor of Medicine (BMed), Guangxi University of Chinese Medicine, P.R. China
- Member, Natural Therapies Working Committee (NTWC), National Health & Medical Research Council, Australian Government
- Invited Expert, Chinese Medicine Board of Australia Regulatory Examinations Development Group
- Consultant, World Health Organisation Western Pacific Regional Office (WHO-WPRO), WHO
- Expert Advisor (Assessor), Tertiary Education Quality and Standards Agency (TEQSA)
- External Reviewer, National Health & Medical Research Council (NHMRC)
- External Assessor, Australian Research Council (ARC)
- External Assessor, Office for Learning and Teaching Grants, Australian Government
- External Reviewer, Health Research Council, New Zealand Government
- Grant Review Referee Panel (2014-present, reviewed >30 grant applications), Health and Medical Research Fund, Hong Kong Government
- HDR Thesis Examiner: Sydney University, University of New South Wales, Deakin University, La Trobe University, University Technology of Sydney, Charles Sturt University, Griffith University, University of Western Sydney, Central Queensland University
- Panel Member, Accreditation of Master of Science Program, Hong Kong Baptist University
- Vetting Panel, BSci (Hons) Chinese Med, International Medical University, Malaysia
Editorial Board Member (n=7)
- American Journal of Chinese Medicine (IF=2.959, Q1)
- BMC Complementary Medicine and Therapies (IF=2.610, Q1)
- Discovery Phytomedicine (ISSN 3698-7859)
- Journal of Acupuncture and Herbs (ISSN 2001-7464)
- Journal of Traditional Chinese Medicine (ISSN 0254-6272)
- Journal of Acupuncture Research (ISSN 2586-288X)
- Longhua Chinese Medicine (ISSN 2616-2806)
- Liu, M.,Di, Y.,Zhang, T.,Chen, J.,Wang, R.,Huang, J.,Zhang, L.,Xue, C.,Liu, X. (2024). Renal-protective effects of Chinese medicinal herbs and compounds for diabetic kidney disease in animal models: protocol for systematic review and meta-analysis In: Systematic Reviews, 13, 1 - 8
- May, B.,Xia, X.,Zhang, A.,Xue, C.,Lu, C.,Li, Y.,Guo, X. (2023). Evidence-Based Clinical Chinese Medicine - Volume 26: Rheumatoid Arthritis, World Scientific, Singapore
- Pang, J.,Planche, J.,Zheng, L.,Liu, S.,Zhang, A.,Lin, L.,Xue, C.,Wu, L. (2023). Clinical evidence for acupuncture for adult asthma: Systematic review and meta-analysis of randomised sham/placebo-controlled trials In: Complementary Therapies in Medicine, 75, 1 - 10
- Wang, Y.,Coyle, M.,Hong, M.,He, S.,Zhang, A.,Guo, X.,Lu, C.,Xue, C.,Liang, X. (2023). Acupuncture and moxibustion for endometriosis: A systematic review and analysis In: Complementary Therapies in Medicine, 76, 1 - 10
- Guo, Q.,Zhang, A.,Xue, C.,Coyle, M.,Chen, Q. (2023). A Delphi Study of Expert Consensus on Chinese Medicine Syndrome Differentiation and Herbal Use for Early Breast Cancer In: Integrative Cancer Therapies, 22, 1 - 8
- Liu, Y.,May, B.,Hyde, A.,He, Y.,Guo, X.,Zhang, A.,Lu, C.,Xue, C.,Zhang, H. (2023). Topical Traditional Chinese Medicines for Cancer Pain: A Systematic Review and Meta-analysis of Randomized Controlled Trials In: Integr Cancer Ther ., 22, 1 - 14
- Cheng, Y.,Di, Y.,Zhang, A.,Zhang, B.,Xue, C. (2023). Oral Chinese herbal medicine in reducing the recurrence of colorectal adenoma after polypectomy: A protocol for the systematic review and meta-analysis In: PLoS ONE, 18, 1 - 10
- Cui, J.,Lin, W.,May, B.,Luo, Q.,Worsnop, C.,Zhang, A.,Guo, X.,Lu, C.,Li, Y.,Xue, C. (2023). Orally administered Chinese herbal therapy to assist post-surgical recovery for chronic rhinosinusitis—A systematic review and meta-analysis In: PLoS ONE, 18, 1 - 24
- Liu, S.,Guo, X.,Wu, D.,Zhang, A.,Xue, C.,Wen, Z. (2023). Construction of Clinical Evidence Grading System of TCM Intervention Based on Evidence-based Medicine Principles In: Chinese Journal of Integrated Medicine, 43, 1885 - 1889
- Cheng, Y.,Di, Y.,Zhang, A.,Hu, P.,Mo, J.,Zhang, H.,Xue, C.,Zhang, B. (2023). Does Chinese herbal medicine (CHM) reduce colorectal adenoma (CRA) recurrence: Protocol of a registry-based, cohort study and a qualitative interview In: BMJ Open, 13, 1 - 20
Note: Supervision projects since 2004
23 PhD Completions and 1 Masters by Research Completions6 PhD Current Supervisions
- Culture aspects in the Development of evidence-based Chinese Medicine - Stage 9. Funded by: Confucius Institute Headquarters Business Development Program Grant 2017 from (2019 to 2020)
- Culture aspects in the Development of evidence-based Chinese Medicine - Stage 7. Funded by: Confucius Institute Headquarters Business Development Program Grant 2017 from (2017 to 2019)
- Culture aspects in the Development of evidence-based Chinese Medicine - Stage 6. Funded by: Confucius Institute Headquarters Business Development Program Grant 2016 from (2016 to 2018)
- Cultural Aspects in the Development of Evidence-Based Chinese Medicine - Stage 5. Funded by: Confucius Institute Headquarters Business Development Program Grant pre-2014 from (2015 to 2018)
- Cultural Aspects in the Development of Evidence-Based Chinese Medicine - Stage 4. Funded by: Confucius Institute Headquarters Business Development Program Grant pre-2014 from (2014 to 2014)